Similar to the results obtained from ILD fibroblast co-culture in different seeding densities, IL11 treatment of alveolar organoid monocultures resulted in a dose dependent increase in metabolic activity, elevated expression of mesenchymal markers and decreased AT2 stemness and identity. The gene discussed is IL11; the disease is interstitial lung disease.